Condensed financial information (Parent Company only) (Tables)

12 Months Ended

Dec. 31, 2023

Condensed Financial Information Disclosure [Abstract]

Condensed balance sheet

	December 31,
	2023		2022
Assets
Current assets:
Cash and cash equivalents	$	—	$	—
Total current assets	—		—
Investment in subsidiaries	717,547		701,338
Total assets	$	717,547	$	701,338
Liabilities and stockholders’ equity
Current liabilities:
Accrued liabilities	$	—	$	—
Total current liabilities	—		—
Other liabilities	—		—
Total liabilities	—		—
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 50,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022	—		—
Common stock, $0.001 par value, 500,000,000 shares authorized at December 31, 2023 and 2022; 126,938,102 and 123,170,172 shares issued and outstanding at December 31, 2023 and 2022, respectively	126		123
Additional paid-in capital	1,162,993		1,049,875
Accumulated other comprehensive loss	(26,777)		(39,951)
Accumulated deficit	(418,795)		(308,709)
Total stockholders’ equity	717,547		701,338
Total liabilities and stockholders’ equity	$	717,547	$	701,338

Condensed income statement

	Years Ended December 31,
	2023		2022		2021
Revenue	$	—	$	—	$	—
Operating expenses	—		—		—
Loss from operations	—		—		—
Other income, net	—		—		—
Loss before income tax (provision) benefit and equity in net loss of subsidiaries	—		—		—
Income tax (provision) benefit	—		—		—
Equity in net loss of subsidiaries	(110,086)		(141,301)		(75,189)
Net loss	$	(110,086)	$	(141,301)	$	(75,189)

Condensed statement of comprehensive loss

	Years Ended December 31,
	2023		2022		2021
Net loss	$	(110,086)	$	(141,301)	$	(75,189)
Other comprehensive income (loss):
Subsidiaries’ other comprehensive income (loss)	13,174		(32,085)		(7,866)
Total other comprehensive income (loss)	13,174		(32,085)		(7,866)
Comprehensive loss	$	(96,912)	$	(173,386)	$	(83,055)